DWTXDogwood Therapeutics, Inc. insider trades
No insider bought or sold Dogwood Therapeutics, Inc. (DWTX) shares on the open market in the last 90 days. The latest Form 4 transaction on record was filed on Oct 27.
- Market cap
- $39.43M
- as of 2026-10-27
- Latest close
- $1.16
- as of 2026-10-27
- Sector
- Healthcare
- as of 2026-10-27
- Industry
- Biotechnology
- as of 2026-10-27
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-28
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sealbond Ltd | Oct 26 | Oct 27 | A | 4,098,360 | $1.22 | $4,999,999 | 25,920,693 | No | Form 4 |
| Thomas John C | Jun 16 | Jun 17 | A · derivative | 16,800 | $1.50 | $25,200 | 16,800 | No | Form 4 |
| Whitley Richard James | Jun 16 | Jun 17 | A · derivative | 16,800 | $1.50 | $25,200 | 16,800 | No | Form 4 |
| De La Rosa Abel | Jun 16 | Jun 17 | A · derivative | 16,800 | $1.50 | $25,200 | 16,800 | No | Form 4 |
| Keefer David R | Jun 16 | Jun 17 | A · derivative | 16,800 | $1.50 | $25,200 | 16,800 | No | Form 4 |
| Walsh AngelaChief Financial Officer | Mar 5 | Mar 6 | A · derivative | 82,500 | $2.86 | $235,950 | 82,500 | No | Form 4 |
| Grosswald RalphSVP OF OPERATIONS | Mar 5 | Mar 6 | A · derivative | 82,500 | $2.86 | $235,950 | 82,500 | No | Form 4 |
| Gendreau Roger MichaelCHIEF MEDICAL OFFICER | Mar 5 | Mar 6 | A · derivative | 82,500 | $2.86 | $235,950 | 82,500 | No | Form 4 |
| Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | Mar 5 | Mar 6 | A · derivative | 330,000 | $2.86 | $943,800 | 330,000 | No | Form 4 |
| Walsh AngelaChief Financial Officer | Dec 4, 2025 | Dec 5, 2025 | A · derivative | 150,000 | $6.14 | $921,000 | 150,000 | No | Form 4 |
| Grosswald RalphSVP OF OPERATIONS | Dec 4, 2025 | Dec 5, 2025 | A · derivative | 150,000 | $6.14 | $921,000 | 150,000 | No | Form 4 |
| Gendreau Roger MichaelCHIEF MEDICAL OFFICER | Dec 4, 2025 | Dec 5, 2025 | A · derivative | 150,000 | $6.14 | $921,000 | 150,000 | No | Form 4 |
| Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | Dec 4, 2025 | Dec 5, 2025 | A · derivative | 460,000 | $6.14 | $2,824,400 | 460,000 | No | Form 4 |
| Conjoint Inc. | Nov 21, 2025 | Nov 25, 2025 | C | 21,610,950 | not reported | not reported | 21,822,333 | No | Form 4 |
| Conjoint Inc. | Nov 21, 2025 | Nov 25, 2025 | C | 2,842,638 | not reported | not reported | 2,842,638 | No | Form 4 |
| Conjoint Inc. | Nov 21, 2025 | Nov 25, 2025 | C · derivative | 2,161.1 | $0.00 | $0 | not reported | No | Form 4 |
| Conjoint Inc. | Nov 21, 2025 | Nov 25, 2025 | C · derivative | 284.26 | $0.00 | $0 | not reported | No | Form 4 |
| De La Rosa Abel | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 2,362 | $4.71 | $11,125 | 2,362 | No | Form 4 |
| Walsh AngelaChief Financial Officer | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 12,075 | $4.71 | $56,873 | 12,075 | No | Form 4 |
| Keefer David R | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 2,362 | $4.71 | $11,125 | 2,362 | No | Form 4 |
| Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 40,000 | $4.71 | $188,400 | 40,000 | No | Form 4 |
| Thomas John C | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 2,362 | $4.71 | $11,125 | 2,362 | No | Form 4 |
| Grosswald RalphSVP OF OPERATIONS | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 12,075 | $4.71 | $56,873 | 12,075 | No | Form 4 |
| Whitley Richard James | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 2,362 | $4.71 | $11,125 | 2,362 | No | Form 4 |
| Gendreau Roger MichaelCHIEF MEDICAL OFFICER | Jun 27, 2025 | Jul 1, 2025 | A · derivative | 12,075 | $4.71 | $56,873 | 12,075 | No | Form 4 |
| De La Rosa Abel | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 210 | No | Form 4 |
| De La Rosa Abel | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 420 | No | Form 4 |
| Thomas John C | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 210 | No | Form 4 |
| Thomas John C | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 420 | No | Form 4 |
| Keefer David R | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 210 | No | Form 4 |
| Keefer David R | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 420 | No | Form 4 |
| Whitley Richard James | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 210 | No | Form 4 |
| Whitley Richard James | Jun 18, 2025 | Jun 23, 2025 | A · derivative | 210 | $4.80 | $1,008 | 420 | No | Form 4 |
| CK Life Sciences Intl (Holdings) Inc | Mar 12, 2025 | Mar 17, 2025 | A · derivative | 284.26 | $7.01 | $1,993 | 284.26 | No | Form 4 |
| Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 138,835 | $0.36 | $49,981 | 138,835 | No | Form 4 |
| Gendreau Roger MichaelCHIEF MEDICAL OFFICER | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 88,085 | $0.36 | $31,711 | 88,085 | No | Form 4 |
| Grosswald RalphSVP OF OPERATIONS | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 62,568 | $0.36 | $22,524 | 62,568 | No | Form 4 |
| Walsh AngelaSVP OF FINANCE | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 63,618 | $0.36 | $22,902 | 63,618 | No | Form 4 |
| De La Rosa Abel | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 3,959 | $0.36 | $1,425 | 3,959 | No | Form 4 |
| Burch Richard Alan | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 2,917 | $0.36 | $1,050 | 2,917 | No | Form 4 |
| Keefer David R | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 4,709 | $0.36 | $1,695 | 4,709 | No | Form 4 |
| Whitley Richard James | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 4,000 | $0.36 | $1,440 | 4,000 | No | Form 4 |
| Thomas John C | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 4,167 | $0.36 | $1,500 | 4,167 | No | Form 4 |
| Pridgen William | Feb 26, 2024 | Feb 28, 2024 | A · derivative | 2,917 | $0.36 | $1,050 | 2,917 | No | Form 4 |